Recently, the Connected Health Initiative (CHI) sent newly-appointed U.S. Food and Drug Administration (FDA) Commissioner Dr. Stephen Hahn a welcome letter outlining CHI’s current advocacy on digital health regulations before the agency. Commissioner Hahn joins FDA at a critical time for furthering use of connected health tools and has a [...]
Key Lessons from the 14 Amicus Briefs Filed in Support of the FTC in the Ninth Circuit Court of Appeals In a key court case poised to make or break the innovation cycle in America, Qualcomm and its allies are recycling the same tired arguments in their effort to overturn [...]
The Connected Health Initiative (CHI) spends our year addressing a wide range of digital health issues, but one of the most pressing issues in 2019 is health data interoperability. The efficacy of precision medicine, population health, clinical decision support—and artificial intelligence (AI)-driven tools in particular—depend in large part on the [...]
On Wednesday, July 10, the Federal Communications Commission’s (FCC or Commission) commissioners will meet publicly to vote on a range of items, including a Notice of Proposed Rulemaking (NPRM) proposing to establish a three-year, $100 million pilot program to help healthcare providers cover the cost of broadband service that will [...]
In a highly-anticipated decision in the Federal Trade Commission’s (FTC) antitrust enforcement case against Qualcomm, U.S. District Court judge Lucy Koh found that Qualcomm’s licensing practices clearly violate U.S. antitrust law and rejected U.S. Department of Justice’s Assistant Attorney General for Antitrust Makan Delrahim’s newfangled legal theory that competition law [...]